{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T17:49:21Z","timestamp":1661276961056},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,6,13]]},"DOI":"10.18632\/oncotarget.16957","type":"journal-article","created":{"date-parts":[[2017,4,8]],"date-time":"2017-04-08T14:52:38Z","timestamp":1491663158000},"page":"38642-38649","source":"Crossref","is-referenced-by-count":3,"title":["A mathematical theory of the transcription repression (TR) therapy of cancer - whether and how it may work"],"prefix":"10.18632","volume":"8","author":[{"given":"Yuxin","family":"Chen","sequence":"first","affiliation":[{"name":"State Key Laboratory of Bio-control, School of Life Science, Sun Yat-Sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haijun","family":"Wen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bio-control, School of Life Science, Sun Yat-Sen University, Guangzhou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-I","family":"Wu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Bio-control, School of Life Science, Sun Yat-Sen University, Guangzhou, China"},{"name":"Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing, China"},{"name":"Department of Ecology and Evolution, University of Chicago, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,4,8]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1749-6632.1960.tb20168.x","article-title":"Clinical studies of actinomycin D","volume":"89","author":"Watne","year":"1960","journal-title":"Annals New York Academy of Science"},{"key":"2","first-page":"5987","article-title":"Short exposure to actinomycin D induces \u201creversible\u201d translocation of protein B23 as well as \u201creversible\u201d inhibition of cell growth and RNA synthesis in Hela cells","volume":"50","author":"Chan","year":"1990","journal-title":"Cancer Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1200\/JCO.1998.16.1.237","article-title":"Comparison between single dose and divided dose administration of dactinomycin and doxorubicin for parients with wilms tumor a report form the national wilms tumor study group","volume":"16","author":"Breslow","year":"1998","journal-title":"J Clinical Oncology"},{"key":"4","first-page":"107","article-title":"Changes in extranuleolar transcription during actinomycin D induced apoptosis","author":"Fraschini","year":"2005","journal-title":"Histology and Histopathology"},{"key":"5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-015-0489-8","article-title":"Effect of low doses of actinomycin D on neuroblastoma cell lines","volume":"15","author":"Tauler","year":"2016","journal-title":"Mol Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"10666","DOI":"10.1073\/pnas.1611481113","article-title":"Actinomycin D enhances killing of cancer cells by immunotoxin RG7787 through activation of the extrinsic pathway of apoptosis","volume":"113","author":"Pastan","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/bcp.12878","article-title":"Development of a physiologically based pharmacokinetic model of actinomycin D in children with cancer","volume":"81","author":"Veal","year":"2016","journal-title":"Br J Clin Pharmacol"},{"key":"8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.172.3983.577","article-title":"renewed RNA synthesis after removal from mammalian cells","volume":"172","author":"Actinomycin","year":"1971","journal-title":"Science"},{"key":"9","doi-asserted-by":"crossref","first-page":"12416","DOI":"10.1074\/jbc.M109.074211","article-title":"Chemotherapeutic drugs inhibit ribosome biogenesis at various levels","volume":"285","author":"Eick","year":"2010","journal-title":"J Biol Chem"},{"key":"10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Welch","year":"2013","journal-title":"Nature"},{"key":"11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Getz","year":"2014","journal-title":"Nature"},{"key":"12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev-genet-112414-054842","article-title":"The Ecology and Evolution of Cancer: The Ultra-Microevolutionary Process","volume":"50","author":"Lu","year":"2016","journal-title":"Annu Rev Genet"},{"key":"13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nrm1551","article-title":"RNA polymerases I and III, growth control and cancer","volume":"6","author":"White","year":"2005","journal-title":"Nature reviews Molecular cell biology"},{"key":"14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.pharmtox.010909.105844","article-title":"The RNA polymerase I transcription machinery: an emerging target for the treatment of cancer","volume":"50","author":"Grummt","year":"2010","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"15","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-10-1728","article-title":"Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth","volume":"71","author":"Sanij","year":"2011","journal-title":"Cancer Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.cell.2011.04.021","article-title":"Paused RNA polymerase II as a developmental checkpoint","volume":"145","author":"Levine","year":"2011","journal-title":"Cell"},{"key":"17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ccr.2012.05.019","article-title":"Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53","volume":"22","author":"Bliesath","year":"2012","journal-title":"Cancer Cell"},{"key":"18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrc3496","article-title":"Dysregulation of the basal RNA polymerase transcription apparatus in cancer","volume":"13","author":"Hannan","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2050-6511-14-32","article-title":"Efficacy of RNA polymerase II inhibitors in targeting dormant leukaemia cells","volume":"14","author":"Whittall","year":"2013","journal-title":"BMC Pharmacol Toxicol"},{"key":"20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ccell.2014.10.019","article-title":"Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor","volume":"26","author":"Capelletti","year":"2014","journal-title":"Cancer Cell"},{"key":"21","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nature13393","article-title":"Targeting transcription regulation in cancer with a covalent CDK7 inhibitor","volume":"511","author":"McMillin","year":"2014","journal-title":"Nature"},{"key":"22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0092-8674(74)90107-X","article-title":"Chages in RNA in relation to growth of fibrablast II the lifetime of mRNA, rRAN, and tRNA in resting and growing cell","volume":"1","author":"Abelson","year":"1974","journal-title":"Cell"},{"key":"23","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1128\/MCB.23.5.1558-1568.2003","article-title":"In Exponentially Growing Saccharomyces cerevisiae Cells, rRNA Synthesis Is Determined by the Summed RNA Polymerase I Loading Rate Rather than by the Number of Active Genes","volume":"23","author":"Beyer","year":"2003","journal-title":"Molecular and Cellular Biology"},{"key":"24","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2353\/ajpath.2008.070752","article-title":"Nucleolus, ribosomes, and cancer","volume":"173","author":"Derenzini","year":"2008","journal-title":"Am J Pathol"},{"key":"25","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/jcp.24854","article-title":"Regulation of Ribosomal Gene Expression in Cancer","volume":"230","author":"Mitchell","year":"2015","journal-title":"Journal of Cellular Physiology"},{"key":"26","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1101\/gr.1272403","article-title":"Decay rates of human mRNAs: Correlation with functional characteristics and sequence attributes","volume":"13","author":"Darnell","year":"2003","journal-title":"Genome research"},{"key":"27","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1101\/gr.130559.111","article-title":"Genome-wide determination of RNA stability reveals hundreds of short-lived noncoding transcripts in mammals","volume":"22","author":"Akimitsu","year":"2012","journal-title":"Genome research"},{"key":"28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1365-2184.2007.00448.x","article-title":"Different effects of ribosome biogenesis inhibition on cell proliferation in retinoblastoma protein and p53 dificient and proficient human osteosarcoma cell lines","volume":"40","author":"Mazzini","year":"2007","journal-title":"Cell Prolif"},{"key":"29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ncponc0558","article-title":"Mechanisms of disease: Oncogene addiction\u2014a rationale for molecular targeting in cancer therapy","volume":"3","author":"Joe","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","article-title":"Transcriptional Addiction in Cancer","volume":"168","author":"Young","year":"2017","journal-title":"Cell"},{"key":"31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/541269a","article-title":"Reproducibility project yields muddy results","volume":"541","author":"Dolgin","year":"2017","journal-title":"Nature"},{"key":"32","first-page":"6","article-title":"The challenges of replication","author":"Editorial","year":"2017","journal-title":"eLife"},{"key":"33","first-page":"6","article-title":"Making sense of replications","author":"Errington","year":"2017","journal-title":"eLife"},{"key":"34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1570-0232(03)00573-7","article-title":"Determination of anti-cancer drug actinomycin D in human plasma by liquid chromatography-mass spectrometry","volume":"795","author":"Boddy","year":"2003","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"35","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1016\/j.ejca.2013.06.038","article-title":"Low-dose metronomic chemotherapy: a systematic literature analysis","volume":"49","author":"Emmenegger","year":"2013","journal-title":"Eur J Cancer"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T09:37:14Z","timestamp":1658914634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.16957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,8]]},"references-count":35,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2017,6,13]]}},"alternative-id":["16957","28454100"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.16957","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,8]]}}}